Pharma & Biotech

A significant period of technical support for Ypsomed shares is set to end next Tuesday. The Swiss medical technology specialist...

Biotechnology firm Onco-Innovations has fortified its financial position by completing a private placement, securing crucial capital for its preclinical cancer...

The German biotech firm BioNTech is navigating its most significant strategic transition to date. Two concurrent developments have unsettled the...

Pharmaceutical giant Eli Lilly issued a significant public safety alert on March 12, 2026, concerning chemically contaminated compounded versions of...

In a strategic pivot that reshapes its market position, telehealth provider Hims & Hers Health has entered a major collaboration...

Animal health company Zoetis is confronting a challenging market phase, characterized by stock price pressure and a cooling companion animal...

Investor attention is turning toward Biomea Fusion as the biotechnology firm advances its therapeutic candidates for diabetes and obesity. The...

The oncology sector is entering a period of intense scrutiny, with 2026 broadly viewed as a watershed year for late-stage...

The pharmaceutical giant Pfizer faces a pivotal strategic moment as it approaches 2026. The company is navigating a complex transition,...

Axsome Therapeutics has surpassed the $500 million revenue mark in the third year since launching its antidepressant, Auvelity. This commercial...